Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James Fox currently holds 182,017 shares of GenMark Diagnostics, Inc. (GNMK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Fox has been a net buyer of GNMK stock. They have purchased $613.7K and sold $0 worth of shares.
James Fox's most recent insider trade was on Apr 22, 2021, when they sold 81,085 shares at $24.05 per share.
James Fox serves as Executive at GenMark Diagnostics, Inc. (GNMK). They have executed 25 insider transactions totaling $613.7K over their tenure at the company.
James Fox holds the position of Executive at GenMark Diagnostics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
James Fox has shown a buying trading pattern, with $613.7K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by James Fox was on Apr 22, 2021, when they sold $4.4M worth of GNMK shares. This transaction involved 182,017 shares at $24.05 per share.
James Fox currently owns 182,017 shares of GenMark Diagnostics, Inc. (GNMK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James Fox's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James Fox has 25 Form 4 filings on record as an insider at GenMark Diagnostics, Inc..
Set alerts for James Fox and 40,000+ other insiders.